News
Ad watchdog announces crackdown on weight loss drug promotion - All advertisements for prescription-only weight-loss ...
The Advertising Standards Authority said a search in January found 1,800 unique paid-for weight-loss ads which were ...
The advertising watchdog has launched a crackdown on the advertising of prescription-only weight-loss medication, warning ...
The "Liver Fibrosis & NASH/MASH Drugs Market Report 2025-2035" has been added to ResearchAndMarkets.com's offering.World revenue for the Liver Fibrosis & NASH/MASH Drugs Market is set to surpass US$18 ...
Plans to ban junk food ads from bus stops and billboards to protect public health are being stymied by advertising industry ...
It’s hard to defend a lot of the stuff that happened in that period but, in retrospect, it moved some boundaries that needed ...
New compelling results demonstrate 18 months of both sustained reduction in immunoglobulin G antibodies and sustained improvement in gMG symptoms in pivotal Vivacity-MG3 study and open label extension ...
A “deplorable” teen driver without a licence killed his half-brother in a high-speed horror crash in a stolen car while he ...
Britain’s government is placing Russia on the top tier of a government security program aimed at protecting the U.K. from malign foreign influence. Home Office minister Dan Jarvis said anyone ...
Residents of Weymouth in Dorset are frustrated at an increase of crime and drug abuse. Relying on tourism, they claim the ...
Holiday business owners and residents in a famous seaside resort say it is being ruined by "moronic" antisocial behaviour - ...
UK-based Exscientia has been working with Japanese pharma Sumitomo Dainippon Pharma (DSP) on the drug for obsessive-compulsive disorder (OCD), and the trial aims to measure its efficacy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results